Matches in Wikidata for { <http://www.wikidata.org/entity/Q63393972> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q63393972 description "clinical trial" @default.
- Q63393972 description "ensayu clínicu" @default.
- Q63393972 description "klinisch onderzoek" @default.
- Q63393972 description "клінічне випробування" @default.
- Q63393972 name "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]" @default.
- Q63393972 type Item @default.
- Q63393972 label "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]" @default.
- Q63393972 prefLabel "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]" @default.
- Q63393972 P1050 Q63393972-07AB8B37-9DFB-4AA5-9889-948C4A059270 @default.
- Q63393972 P1132 Q63393972-C7A6C153-2139-46A7-AFED-F21E9ED0AA4B @default.
- Q63393972 P1476 Q63393972-3903F553-492B-4245-8069-8F60CF1D766A @default.
- Q63393972 P17 Q63393972-38D591F0-BD3F-41BE-B92B-BC7B7BA20ED9 @default.
- Q63393972 P17 Q63393972-CF45407E-19F4-49DC-9DB0-57BFBE506E2E @default.
- Q63393972 P2899 Q63393972-D267CEB8-B585-4DEE-AA4B-03AD251A9458 @default.
- Q63393972 P3098 Q63393972-C7A67ECF-8490-42F0-B280-381DA4E36B6E @default.
- Q63393972 P31 Q63393972-65D0E027-FAD6-4AF2-A7EA-F0996992A60F @default.
- Q63393972 P4135 Q63393972-10251337-9EEA-4256-B06B-DD0265268C5B @default.
- Q63393972 P4844 Q63393972-74CE94D5-D435-466C-AB39-51E6EBFFFF98 @default.
- Q63393972 P580 Q63393972-A8162AF3-8FE1-47D1-9775-AAF30AB087C4 @default.
- Q63393972 P582 Q63393972-55CDFCB9-56F5-4191-B9BC-2FE9DA783DBF @default.
- Q63393972 P6099 Q63393972-F6203929-E145-4110-8B39-81815743F456 @default.
- Q63393972 P8363 Q63393972-437DE10F-E554-4757-AF63-F13372FF259E @default.
- Q63393972 P1050 Q2453464 @default.
- Q63393972 P1132 "+375" @default.
- Q63393972 P1476 "A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis" @default.
- Q63393972 P17 Q16 @default.
- Q63393972 P17 Q30 @default.
- Q63393972 P2899 "+18" @default.
- Q63393972 P3098 "NCT03616821" @default.
- Q63393972 P31 Q30612 @default.
- Q63393972 P4135 "+80" @default.
- Q63393972 P4844 Q7918002 @default.
- Q63393972 P580 "2018-08-07T00:00:00Z" @default.
- Q63393972 P582 "2019-11-08T00:00:00Z" @default.
- Q63393972 P6099 Q42824440 @default.
- Q63393972 P8363 Q78089383 @default.